Bell D L, Leslie-Mazwi T M, Yoo A J, Rabinov J D, Butler W E, Bell J E, Hirsch J A
From the Department of Radiology, Neuroendovascular Program (D.L.B., A.J.Y., J.D.R., J.A.H.) Harvard Medical School (D.L.B., T.M.L.-M., J.D.R., W.E.B., J.A.H.), Boston, Massachusetts
Department of Neurology and Radiology, Neurocritical Care and Neuroendovascular Program (T.M.L.-M.) Harvard Medical School (D.L.B., T.M.L.-M., J.D.R., W.E.B., J.A.H.), Boston, Massachusetts.
AJNR Am J Neuroradiol. 2015 Jul;36(7):1303-9. doi: 10.3174/ajnr.A4286. Epub 2015 Apr 9.
The advent of modern neuroendovascular techniques has highlighted the need for a simple, effective, and reliable brain arteriovenous malformation endovascular grading scale. A novel scale of this type has recently been described. It incorporates the number of feeding arteries, eloquence, and the presence of an arteriovenous fistula component. Our aim is to assess the validity of this grading scale.
We retrospectively reviewed all suspected brain arteriovenous malformations at Massachusetts General Hospital from 2005 to 2013, identifying 126 patients who met the inclusion criteria. Spearman correlations between endovascular and Spetzler-Martin grading scales and long-term outcomes were performed. Median endovascular grades were compared between treatment modalities and endovascular outcomes. Binary regression analysis was performed with major endovascular complications as a dichotomized dependent variable. Intraclass correlation coefficients were calculated for interobserver reliability of the endovascular grading scale.
A significant Spearman correlation between the endovascular grade and the Spetzler-Martin grade was demonstrated (ρ = 0.5, P < .01). Differences in the median endovascular grades between the endovascular cure (median = 2) and endovascular complication groups (median = 4) (P < .05) and between the endovascular cure and successful multimodal treatment groups (median = 3) (P < .05) were demonstrated. The endovascular grade was the only independent predictor of complications (OR = 0.5, P < .01). The intraclass correlation coefficient of the endovascular grade was 0.71 (P < .01).
Validation of a brain arteriovenous malformation endovascular grading scale demonstrated that endovascular grades of ≤II were associated with endovascular cure, while endovascular grades of ≤III were associated with multimodal cure or significant lesion reduction and favorable outcome. The endovascular grade provides useful information to refine risk stratification for endovascular and multimodal treatment.
现代神经血管内技术的出现凸显了对一种简单、有效且可靠的脑动静脉畸形血管内分级量表的需求。最近描述了一种此类新型量表。它纳入了供血动脉数量、功能区受累情况以及动静脉瘘成分的存在与否。我们的目的是评估该分级量表的有效性。
我们回顾性分析了2005年至2013年在马萨诸塞州总医院所有疑似脑动静脉畸形的病例,确定了126例符合纳入标准的患者。对血管内分级量表与Spetzler-Martin分级量表之间以及与长期预后进行了Spearman相关性分析。比较了不同治疗方式之间的血管内分级中位数以及血管内治疗结果。以主要血管内并发症作为二分法因变量进行二元回归分析。计算了血管内分级量表的观察者间可靠性的组内相关系数。
血管内分级与Spetzler-Martin分级之间存在显著的Spearman相关性(ρ = 0.5,P <.01)。血管内治愈组(中位数 = 2)与血管内并发症组(中位数 = 4)之间(P <.05)以及血管内治愈组与成功的多模式治疗组(中位数 = 3)之间(P <.05)的血管内分级中位数存在差异。血管内分级是并发症的唯一独立预测因素(OR = 0.5,P <.01)。血管内分级的组内相关系数为0.71(P <.01)。
脑动静脉畸形血管内分级量表的验证表明,血管内分级≤II与血管内治愈相关,而血管内分级≤III与多模式治愈或病变显著缩小及良好预后相关。血管内分级为血管内治疗和多模式治疗的风险分层提供了有用信息。